Skip to main content
British Heart Journal logoLink to British Heart Journal
. 1994 Sep;72(3):266–268. doi: 10.1136/hrt.72.3.266

Two cases of amiodarone-induced thyrotoxicosis successfully treated with a short course of antithyroid drugs while amiodarone was continued.

M D Trip 1, D R Düren 1, W M Wiersinga 1
PMCID: PMC1025514  PMID: 7946779

Abstract

Two patients with amiodarone-induced thyrotoxicosis were treated successfully with potassium perchlorate and carbimazole while treatment with amiodarone was continued. These antithyroid drugs were stopped after the patients had became clinically and biochemically euthyroid. During follow up, when treatment with amiodarone continued, thyrotoxicosis did not recur. Amiodarone-induced thyrotoxicosis seems to be a transient condition that can be treated successfully with a short course of antithyroid drugs without stopping amiodarone treatment.

Full text

PDF
266

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Brennan M. D., van Heerden J. A., Carney J. A. Amiodarone-associated thyrotoxicosis (AAT): experience with surgical management. Surgery. 1987 Dec;102(6):1062–1067. [PubMed] [Google Scholar]
  2. Martino E., Aghini-Lombardi F., Mariotti S., Lenziardi M., Baschieri L., Braverman L. E., Pinchera A. Treatment of amiodarone associated thyrotoxicosis by simultaneous administration of potassium perchlorate and methimazole. J Endocrinol Invest. 1986 Jun;9(3):201–207. doi: 10.1007/BF03348098. [DOI] [PubMed] [Google Scholar]
  3. Martino E., Macchia E., Aghini-Lombardi F., Antonelli A., Lenziardi M., Concetti R., Fenzi G. F., Baschieri L., Pinchera A. Is humoral thyroid autoimmunity relevant in amiodarone iodine-induced thyrotoxicosis (AIIT)? Clin Endocrinol (Oxf) 1986 Jun;24(6):627–633. doi: 10.1111/j.1365-2265.1986.tb01658.x. [DOI] [PubMed] [Google Scholar]
  4. Reichert L. J., de Rooy H. A. Treatment of amiodarone induced hyperthyroidism with potassium perchlorate and methimazole during amiodarone treatment. BMJ. 1989 Jun 10;298(6687):1547–1548. doi: 10.1136/bmj.298.6687.1547. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Smyrk T. C., Goellner J. R., Brennan M. D., Carney J. A. Pathology of the thyroid in amiodarone-associated thyrotoxicosis. Am J Surg Pathol. 1987 Mar;11(3):197–204. doi: 10.1097/00000478-198703000-00004. [DOI] [PubMed] [Google Scholar]
  6. Trip M. D., Wiersinga W., Plomp T. A. Incidence, predictability, and pathogenesis of amiodarone-induced thyrotoxicosis and hypothyroidism. Am J Med. 1991 Nov;91(5):507–511. doi: 10.1016/0002-9343(91)90187-3. [DOI] [PubMed] [Google Scholar]

Articles from British Heart Journal are provided here courtesy of BMJ Publishing Group

RESOURCES